From NPS Discovery: 2020 Q3 Trend Reports for synthetic cannabinoids, NPS stimulants and hallucinogens, NPS opioids, and NPS benzodiazepines
NPS Discovery released its 2020 Q3 Trend Reports last Friday. An increasing number of emergency room admissions, death investigations, and intoxication events have been caused by synthetic cannabinoids, NPS stimulants, NPS hallucinogens, and NPS opioids in Q3 of 2020. The top NPS identified by class were 5F-MDMB-PICA (synthetic cannabinoids), eutylone (stimulants and hallucinogens), brorphine (opioids), and flualprazolam (benzodiazepines). Read the full trend reports here.